In those infants who develop hypercalcemia, determination of serum 1,25(OH)2D3 and parathyroid hormone (PTH) allows confirmation of PTH-independent hypercalcemia, while regular renal US monitoring is required to detect nephrocalcinosis (76). The gene discussed is PTH; the disease is hypercalcemia disease.